Terms: = Liver cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Diagnosis
74 results:
1. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
[TBL] [Abstract] [Full Text] [Related]
2. Case Report: Complete pathological remission of human chorionic gonadotrophin-producing gallbladder carcinoma with multiple liver metastases after treatment with chemotherapy plus an immune checkpoint inhibitor.
Wang Q; Mu Y; Ji S; Liu Y; Lou Y; Wei S; Dong X; Zhang B
Front Immunol; 2023; 14():1173520. PubMed ID: 37841278
[TBL] [Abstract] [Full Text] [Related]
3. Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
Cowzer D; White JB; Chou JF; Chen PJ; Kim TH; Khalil DN; El Dika IH; Columna K; Yaqubie A; Light JS; Shia J; Yarmohammadi H; Erinjeri JP; Wei AC; Jarnagin W; Do RKG; Solit DB; Capanu M; Shah RH; Berger MF; Abou-Alfa GK; Harding JJ
JCO Precis Oncol; 2023 Sep; 7():e2300272. PubMed ID: 37769223
[TBL] [Abstract] [Full Text] [Related]
4. CHSY1 promotes CD8
Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
[TBL] [Abstract] [Full Text] [Related]
5. Effects of LAIR-1 on hepatocellular carcinoma cell proliferation and invasion via pi3k-AKT-mTOR pathway regulation.
Zhou T; Liu L; Lan H; Fang D
Immun Inflamm Dis; 2023 Aug; 11(8):e982. PubMed ID: 37647449
[TBL] [Abstract] [Full Text] [Related]
6. The expression of tuftelin 1 as a new theranostic marker in early diagnosis and as a therapeutic target in hepatocellular carcinoma.
Abdel-Hamid NM; Zakaria SM; Ansary AM; El-Senduny FF; El-Shishtawy MM
Cell Biochem Funct; 2023 Oct; 41(7):788-800. PubMed ID: 37470499
[TBL] [Abstract] [Full Text] [Related]
7. AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations.
Xu Y; Zhang X; Zhang R; Sun Y; Liu J; Luo C; Yang J; Fang W; Guo Q; Wei L
Cancer Lett; 2023 Jul; 566():216240. PubMed ID: 37217071
[TBL] [Abstract] [Full Text] [Related]
8. The Diagnostic and Therapeutic Value of NCAPG as a Proposed Biomarker Candidate in Acute liver Failure.
Zhang L; Ma T; Yan Y; Chen YY; Zhu XH; Ren HZ
Comb Chem High Throughput Screen; 2023; 26(15):2738-2748. PubMed ID: 37066775
[TBL] [Abstract] [Full Text] [Related]
9. Primary and secondary angiosarcomas of the liver: a multi-institutional study of 32 cases.
Liao X; Lai J; Lin J; Zhang D
Hum Pathol; 2023 Jul; 137():10-17. PubMed ID: 37054784
[TBL] [Abstract] [Full Text] [Related]
10. Alpha fetoprotein promotes polarization of macrophages towards M2-like phenotype and inhibits macrophages to phagocytize hepatoma cells.
Zhang M; Liu K; Zhang Q; Xu J; Liu J; Lin H; Lin B; Zhu M; Li M
Front Immunol; 2023; 14():1081572. PubMed ID: 36911723
[TBL] [Abstract] [Full Text] [Related]
11. Construction of Two Independent RAB Family-Based Scoring Systems Based on Machine Learning Algorithms and Definition of RAB13 as a Novel Therapeutic Target for Hepatocellular Carcinoma.
Jiang C; Liu Z; Yuan J; Wu Z; Kong L; Yang J; Lv T
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901767
[TBL] [Abstract] [Full Text] [Related]
12. Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis.
Zhang YZ; Zeb A; Cheng LF
Front Immunol; 2022; 13():1032819. PubMed ID: 36439183
[TBL] [Abstract] [Full Text] [Related]
13. The roles and mechanisms of circular RNAs related to mTOR in cancers.
Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
[TBL] [Abstract] [Full Text] [Related]
14. Pancreatoblastoma in Elderly Adults: Report of Two Patients.
Kulak O; Osipov A; Hendifar AE; Nissen NN; Cox BK; Hruban RH; Hutchings DA
Int J Surg Pathol; 2023 Aug; 31(5):772-777. PubMed ID: 36314453
[No Abstract] [Full Text] [Related]
15. Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer.
Bray AW; Duan R; Malalur P; Drusbosky LM; Gourdin TS; Hill EG; Lilly MB
Prostate; 2022 Sep; 82(13):1264-1272. PubMed ID: 35766303
[TBL] [Abstract] [Full Text] [Related]
16. The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
Zhang JN; Ding DY; Yang SY; Tao QF; Yang Y; Zhou WP
Pathol Res Pract; 2022 Aug; 236():153989. PubMed ID: 35753134
[TBL] [Abstract] [Full Text] [Related]
17. Potential tumor marker for hepatocellular carcinoma identification: pi3k and pro-inflammatory cytokines (TGF-β, IL-1, and IL-6).
Tabakhiyan F; Mir A; Vahedian V
Horm Mol Biol Clin Investig; 2022 Dec; 43(4):389-396. PubMed ID: 35709206
[TBL] [Abstract] [Full Text] [Related]
18. Circulating microRNAs (miR-16, miR-22, miR-122) expression and early diagnosis of hepatocellular carcinoma.
Fang Y; Yan D; Wang L; Zhang J; He Q
J Clin Lab Anal; 2022 Jul; 36(7):e24541. PubMed ID: 35666610
[TBL] [Abstract] [Full Text] [Related]
19. LINC00665: An Emerging Biomarker for cancer Diagnostics and Therapeutics.
Zhong C; Xie Z; Shen J; Jia Y; Duan S
Cells; 2022 May; 11(9):. PubMed ID: 35563845
[TBL] [Abstract] [Full Text] [Related]
20. LINC00963: A potential cancer diagnostic and therapeutic target.
Xie Z; Zhong C; Shen J; Jia Y; Duan S
Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
[TBL] [Abstract] [Full Text] [Related]
[Next]
